21
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Molecular Cloning, Genomic Organization, and Mapping of β4GalT-VIb, a brain Abundant Member of β4-galactosyltransferase Gene Family, to Human Chromosome 18q12.1

, , , , , , , & show all
Pages 1-8 | Published online: 11 Jul 2009
 

Abstract

In the present study, a brain abundant member of &#103 4-galactosyltransferase gene family with an open reading frame encoding 343 amino acids was cloned and identified from a human leukemia cell cDNA library. The putative protein sequence is about 94.8 and 94.2% identical to the 382-amino-acid mouse and rat &#103 4-galactosyltransferase respectively and also contains cysteine residues previously shown to be important for the function of the gene family members. This cDNA (tentatively termed &#103 4GalT-VIb) is identical to a recently reported cDNA (tentatively termed &#103 4GalT-VIa) of human &#103 4-galactosyltransferase except lacking one exon, suggesting that these two cDNAs are two different alternative transcripts of the same gene. Northern hybridization showed that the new alternative transcript, &#103 4GalT-VIb, is expressed in all 16 human tissues tested with highest level in brain and rich level in testis, thymus and pancreas, whereas weak expression was detected in lung. The &#103 4GalT-VIb gene was located to human chromosome 18q12.1 between markers WI-9180 and SGC35630 by radiation hybrid mapping. The genomic organization and adjacent gene content of &#103 4GalT-VIb were identified by comparing its cDNA sequence with three genomic sequences AC017100, AP002474 and AP001336, which showed that &#103 4GalT-VIb spans an ~58 &#117 kb region and is composed of 8 exons. In addition, the most conserved motif composed of 41 residues, LXYX 3 FGGVSXL(T/S)X 2 QFX 2 INGFPNX(Y/F)WGWGGEDDDX 2 NR, was defined according to 17 sequences of &#103 4GalTs from seven different organisms for the first time.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.